Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

110.18
Delayed Data
As of Jul 31
 +1.27 / +1.17%
Today’s Change
36.44
Today|||52-Week Range
138.85
-1.66%
Year-to-Date

Today’s Trading

Previous close108.91
Today’s open109.57
Day’s range108.06 - 112.56
Volume249,453
Average volume (3 months)605,527
Market cap$4.2B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-31.17%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book9.78

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc-0.27-0.76%
BRLIBio-Reference Labora...-0.12-0.27%
GNMKGenMark Diagnostics ...+0.02+0.24%
NEONeogenomics Inc+0.06+0.99%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Operating Officer
John Duncan Higgons
Corporate headquarters
Cambridge, Massachusetts

Forecasts